Results 241 to 250 of about 2,119,412 (309)
Canada's 2009 risk management plan (RMP) framework has not been evaluated for prenatal exposure impact. Conversely, widely used drugs such as nonsteroidal anti‐inflammatory drugs (NSAIDs) lack RMPs. We assessed first‐trimester exposure to RMP‐regulated medications following regulatory interventions and to NSAIDs following safety publications.
Nahiyan Saiyara Khan +4 more
wiley +1 more source
Anti-Obesity Effects of LB-GABA. [PDF]
Han H, Song G, Kim J, Jin H, Lee BY.
europepmc +1 more source
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are increasingly prescribed for type 2 diabetes and weight management. However, conflicting evidence from preclinical, clinical, and pharmacovigilance studies suggests potential neuropsychiatric effects.
Maria J. Alfonso Arvez +6 more
wiley +1 more source
The effect of combining surgical or endoscopic bariatric interventions with anti-obesity medication or probiotics on weight loss: a narrative review. [PDF]
de Waal JR, Nieuwdorp M, Gerdes VEA.
europepmc +1 more source
Investigations Into the Metabolism and Elimination of Tesofensine in Human Urine
This study investigated tesofensine metabolism and urinary elimination after a single 483 μg intake via a dietary supplement. In six volunteers, urine was collected up to 659 h. LC‐HRMS/MS identified four tentative metabolites; maximum urinary concentrations reached 4 ng/mL within 4–48 h.
O. Krug, A. Thomas, M. Thevis
wiley +1 more source
Expression of concern - Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis. [PDF]
The Editors For eClinicalMedicine.
europepmc +1 more source
ABSTRACT Objective Generative AI is now used to access eating disorder (ED) information, yet the suitability of its outputs remains unclear. Using two vignettes, we evaluated generative AI's ability to accurately identify ED presentations and recommend appropriate care, while benchmarking its performance against published responses from human samples ...
Jake Linardon, Mariel Messer
wiley +1 more source
Gastrointestinal Adverse Effects of Anti-Obesity Medications in Non-Diabetic Adults: A Systematic Review. [PDF]
Takrori E, Peshin S, Singal S.
europepmc +1 more source
ABSTRACT Objective Fear of fat may reflect concern regarding rejection one may experience at a higher weight. Peers play a major role in socialization and support during adolescence and young adulthood. While studies have highlighted peers as an important source of influence underlying disordered eating, it is unclear whether one's own fear of fat or ...
Shannon M. O'Connor +3 more
wiley +1 more source
Mechanisms behind the anti-diabetic and anti-obesity effects of seaweeds or macroalgae and their bioactive compounds. [PDF]
Magwaza SN, Islam MS.
europepmc +1 more source

